Guardion Health Science (GHSI) - יתרות מזומנים בחישוב למניה

סמל ולוגו של המותג Guardion Health (GHSI)

The implementation of AI manipulators in capsule production could boost capitalization, as evidenced by the cash per share trend, where the value is fixed at 11.55. Guardion Health Science (GHSI) revenues are based on the sale of Lumega-Z nutraceuticals designed to combat retinal degeneration. Physician confidence is driven by scientifically proven formulas that slow vision loss, creating a sustainable market advantage.

GHSI Guardion Health: יתרות מזומנים למניה בטווח 04.07.2022 - 19.10.2024

פילוחי מדדים מקיפים ואנליטיקה עבור Guardion Health Sciences (GHSI)

- נתוני מזומנים ותזרימי מזומנים:
ניתוח מסכם של החברה:GHSI (Guardion Health Sciences Inc.)
סחורת הדגל של guardionhealth.com

This metric is calculated by dividing the total cash balance by the number of shares outstanding. This figure compares current capital with historical context to assess financial stability or stagnation. For Guardion Health Science (GHSI), the value 11.55 reflects the liquidity required to automate production lines for ophthalmological nutraceuticals. Investments in AI manipulators directly impact the dynamics of this reserve. By analyzing the current cash per share, an investor determines the company's ability to fund technological expansion.